TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia

Lade...
Vorschaubild
Dateien
Catakovic_2-1drdetzog4c05.pdf
Catakovic_2-1drdetzog4c05.pdfGröße: 1018.86 KBDownloads: 7
Datum
2017
Autor:innen
Catakovic, Kemal
Gassner, Franz Josef
Ratswohl, Christoph
Zaborsky, Nadja
Rebhandl, Stefan
Schubert, Maria
Steiner, Markus
Pleyer, Lisa
Geisberger, Roland
et al.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
OncoImmunology. Taylor & Francis. 2017, 7(1), e1371399. ISSN 2162-4011. eISSN 2162-402X. Available under: doi: 10.1080/2162402x.2017.1371399
Zusammenfassung

While research on T cell exhaustion in context of cancer particularly focuses on CD8+ cytotoxic T cells, the role of inhibitory receptors on CD4+ T-helper cells have remained largely unexplored. TIGIT is a recently identified inhibitory receptor on T cells and natural killer (NK) cells. In this study, we examined TIGIT expression on T cell subsets from CLL patients. While we did not observe any differences in TIGIT expression in CD8+ T cells of healthy controls and CLL cells, we found an enrichment of TIGIT+ T cells in the CD4+ T cell compartment in CLL. Intriguingly, CLL patients with an advanced disease stage displayed elevated numbers of CD4+ TIGIT+ T cells compared to low risk patients. Autologous CLL-T cell co-culture assays revealed that depleting CD4+ TIGIT+ expressing T cells from co-cultures significantly decreased CLL viability. Accordingly, a supportive effect of TIGIT+CD4+ T cells on CLL cells in vitro could be recapitulated by blocking the interaction of TIGIT with its ligands using TIGIT-Fc molecules, which also impeded the T cell specific production of CLL-prosurvival cytokines. Our data reveal that TIGIT+CD4+T cells provide a supportive microenvironment for CLL cells, representing a potential therapeutic target for CLL treatment.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
chronic lymphocytic leukemia, T cell exhaustion, TIGIT, PD-1, microenvironment
Konferenz
Rezension
undefined / . - undefined, undefined
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Datensätze
Zitieren
ISO 690CATAKOVIC, Kemal, Franz Josef GASSNER, Christoph RATSWOHL, Nadja ZABORSKY, Stefan REBHANDL, Maria SCHUBERT, Markus STEINER, Julia C. GUTJAHR, Lisa PLEYER, Roland GEISBERGER, 2017. TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. In: OncoImmunology. Taylor & Francis. 2017, 7(1), e1371399. ISSN 2162-4011. eISSN 2162-402X. Available under: doi: 10.1080/2162402x.2017.1371399
BibTex
@article{Catakovic2017-09-21TIGIT-69212,
  year={2017},
  doi={10.1080/2162402x.2017.1371399},
  title={TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia},
  number={1},
  volume={7},
  issn={2162-4011},
  journal={OncoImmunology},
  author={Catakovic, Kemal and Gassner, Franz Josef and Ratswohl, Christoph and Zaborsky, Nadja and Rebhandl, Stefan and Schubert, Maria and Steiner, Markus and Gutjahr, Julia C. and Pleyer, Lisa and Geisberger, Roland},
  note={Article Number: e1371399}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/69212">
    <dc:creator>Steiner, Markus</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2024-01-31T09:32:08Z</dcterms:available>
    <dc:creator>Gutjahr, Julia C.</dc:creator>
    <dc:creator>Zaborsky, Nadja</dc:creator>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:abstract>While research on T cell exhaustion in context of cancer particularly focuses on CD8+ cytotoxic T cells, the role of inhibitory receptors on CD4+ T-helper cells have remained largely unexplored. TIGIT is a recently identified inhibitory receptor on T cells and natural killer (NK) cells. In this study, we examined TIGIT expression on T cell subsets from CLL patients. While we did not observe any differences in TIGIT expression in CD8+ T cells of healthy controls and CLL cells, we found an enrichment of TIGIT+ T cells in the CD4+ T cell compartment in CLL. Intriguingly, CLL patients with an advanced disease stage displayed elevated numbers of CD4+ TIGIT+ T cells compared to low risk patients. Autologous CLL-T cell co-culture assays revealed that depleting CD4+ TIGIT+ expressing T cells from co-cultures significantly decreased CLL viability. Accordingly, a supportive effect of TIGIT+CD4+ T cells on CLL cells in vitro could be recapitulated by blocking the interaction of TIGIT with its ligands using TIGIT-Fc molecules, which also impeded the T cell specific production of CLL-prosurvival cytokines. Our data reveal that TIGIT+CD4+T cells provide a supportive microenvironment for CLL cells, representing a potential therapeutic target for CLL treatment.</dcterms:abstract>
    <dc:contributor>Geisberger, Roland</dc:contributor>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:creator>Ratswohl, Christoph</dc:creator>
    <dc:contributor>Schubert, Maria</dc:contributor>
    <dc:contributor>Gutjahr, Julia C.</dc:contributor>
    <dc:creator>Pleyer, Lisa</dc:creator>
    <dc:creator>Rebhandl, Stefan</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Gassner, Franz Josef</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/69212"/>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:language>eng</dc:language>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Rebhandl, Stefan</dc:contributor>
    <dc:contributor>Catakovic, Kemal</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2024-01-31T09:32:08Z</dc:date>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/69212/4/Catakovic_2-1drdetzog4c05.pdf"/>
    <dcterms:title>TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia</dcterms:title>
    <dc:contributor>Gassner, Franz Josef</dc:contributor>
    <dc:creator>Schubert, Maria</dc:creator>
    <dc:contributor>Steiner, Markus</dc:contributor>
    <dc:contributor>Zaborsky, Nadja</dc:contributor>
    <dc:contributor>Pleyer, Lisa</dc:contributor>
    <dcterms:issued>2017-09-21</dcterms:issued>
    <dc:contributor>Ratswohl, Christoph</dc:contributor>
    <dc:creator>Geisberger, Roland</dc:creator>
    <dc:creator>Catakovic, Kemal</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/69212/4/Catakovic_2-1drdetzog4c05.pdf"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Ja
Diese Publikation teilen